NCT00594737View on ClinicalTrials.gov

Open Label Pilot Study of the Effects of Memantine on FDG-PET in Frontotemporal Dementia

PHASE3CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions
Frontotemporal Dementia
Interventions
DRUG

memantine hydrochloride

memantine hydrochloride oral tablets, 10mg po bid

Trial Locations (1)

M6A 2E1

Baycrest, Toronto

All Listed Sponsors
collaborator

H. Lundbeck A/S

INDUSTRY

lead

Tiffany Chow, MD

OTHER

NCT00594737 - Open Label Pilot Study of the Effects of Memantine on FDG-PET in Frontotemporal Dementia | Biotech Hunter | Biotech Hunter